CTOs on the Move

Diamedica

www.diamedica.com

 
DiaMedica Inc., a development stage biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of diabetes and related diseases. The company`s lead clinical stage compound is DM199, a recombinant human protein known as rhKLK1, which is under phase I/II clinical trials for the treatment of Type 1 and Type 2 diabetes and associated complications. It is also developing DM204, a monoclonal antibody that is in preclinical development for the treatment of Type 2 diabetes; and DMDx, a chronic kidney disease assay to detect levels of the tissue kallikrein-1 protein in urine and to predict the ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.diamedica.com
  • Two Carlson Parkway Suite 260
    Minneapolis, MN USA 55447
  • Phone: 763.496.5454

Executives

Name Title Contact Details

Funding

Diamedica raised $16M on 12/08/2018

Similar Companies

Saniona

Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs in clinical

Satsuma Pharmaceuticals

Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers.

TBS Dental

We create premium products to make dentistry more efficient. Over the years, TBS has designed and developed a number of contemporary, state-of-the-art instruments with the intent of modernization.

Oncolytics Biotech

Oncolytics Biotech Inc. is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rising Pharmaceuticals

Rising Pharmaceuticals is an industry leader in marketing and distributing innovative branded and multi-source prescription and over-the-counter pharmaceutical products.